| Ashley Turner, APRN-CNM | |
|
1180 E Main St, Columbus, OH 43205-1902 | |
| (614) 645-5500 | |
| Not Available |
| Full Name | Ashley Turner |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 5 Years |
| Location | 1180 E Main St, Columbus, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790376200 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | APRN.CNM.019430 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Columbus Neighborhood Health Center Inc | 3678469129 | 42 |
News Archive
Engineers at the University of California San Diego have developed tiny ultrasound-powered robots that can swim through blood, removing harmful bacteria along with the toxins they produce. These proof-of-concept nanorobots could one day offer a safe and efficient way to detoxify and decontaminate biological fluids.
The IL-1β inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk by reducing inflammation, according to late-breaking results from the CANTOS trial presented today in a Hot Line - LBT Session at ESC Congress1 and published in the NEJM.
A study published in Scientific Reports by researchers at the University of São Paulo in Brazil, in partnership with colleagues in the United States and Norway, shows that the lack of muscle stimulus results in a buildup of inadequately processed proteins in muscle cells and consequently leads to muscle weakness or wasting.
On Feb. 27, 2018, I got an email from the Heritage Foundation, alerting me to a news conference that afternoon held by Republican attorneys general of Texas and other states. It was referred to only as a "discussion about the Affordable Care Act lawsuit."
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard of care for first- and second-line treatment of platinum-sensitive ovarian cancer, pegylated liposomal doxorubicin (PLD)/carboplatin will replace paclitaxel/carboplatin as the standard second-line treatment for patients who remain platinum sensitive.
› Verified 8 days ago
| Entity Name | Columbus Neighborhood Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578985453 PECOS PAC ID: 3678469129 Enrollment ID: O20140721000618 |
News Archive
Engineers at the University of California San Diego have developed tiny ultrasound-powered robots that can swim through blood, removing harmful bacteria along with the toxins they produce. These proof-of-concept nanorobots could one day offer a safe and efficient way to detoxify and decontaminate biological fluids.
The IL-1β inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk by reducing inflammation, according to late-breaking results from the CANTOS trial presented today in a Hot Line - LBT Session at ESC Congress1 and published in the NEJM.
A study published in Scientific Reports by researchers at the University of São Paulo in Brazil, in partnership with colleagues in the United States and Norway, shows that the lack of muscle stimulus results in a buildup of inadequately processed proteins in muscle cells and consequently leads to muscle weakness or wasting.
On Feb. 27, 2018, I got an email from the Heritage Foundation, alerting me to a news conference that afternoon held by Republican attorneys general of Texas and other states. It was referred to only as a "discussion about the Affordable Care Act lawsuit."
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard of care for first- and second-line treatment of platinum-sensitive ovarian cancer, pegylated liposomal doxorubicin (PLD)/carboplatin will replace paclitaxel/carboplatin as the standard second-line treatment for patients who remain platinum sensitive.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Turner, APRN-CNM 11060 Sagamore Rd Nw, Pickerington, OH 43147-1499 Ph: (614) 323-0161 | Ashley Turner, APRN-CNM 1180 E Main St, Columbus, OH 43205-1902 Ph: (614) 645-5500 |
News Archive
Engineers at the University of California San Diego have developed tiny ultrasound-powered robots that can swim through blood, removing harmful bacteria along with the toxins they produce. These proof-of-concept nanorobots could one day offer a safe and efficient way to detoxify and decontaminate biological fluids.
The IL-1β inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk by reducing inflammation, according to late-breaking results from the CANTOS trial presented today in a Hot Line - LBT Session at ESC Congress1 and published in the NEJM.
A study published in Scientific Reports by researchers at the University of São Paulo in Brazil, in partnership with colleagues in the United States and Norway, shows that the lack of muscle stimulus results in a buildup of inadequately processed proteins in muscle cells and consequently leads to muscle weakness or wasting.
On Feb. 27, 2018, I got an email from the Heritage Foundation, alerting me to a news conference that afternoon held by Republican attorneys general of Texas and other states. It was referred to only as a "discussion about the Affordable Care Act lawsuit."
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard of care for first- and second-line treatment of platinum-sensitive ovarian cancer, pegylated liposomal doxorubicin (PLD)/carboplatin will replace paclitaxel/carboplatin as the standard second-line treatment for patients who remain platinum sensitive.
› Verified 8 days ago
Kathleen Elizabeth Waibel, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 921 Jasonway Ave Ste B, Columbus, OH 43214 Phone: 614-268-8800 Fax: 614-447-8876 | |
Kortney Fisher, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 882 S Hamilton Rd, Columbus, OH 43213 Phone: 614-235-5555 | |
Sheryl Catherine Rife, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 921 Jasonway Ave Ste B, Columbus, OH 43214 Phone: 614-916-9730 Fax: 614-447-8876 | |
Mallory B Kahrs, APRN-CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1581 Dodd Dr Fl 4, Columbus, OH 43210 Phone: 614-293-3069 Fax: 614-293-4780 | |
Elizabeth Christy, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 921b Jasonway Ave, Columbus, OH 43214 Phone: 614-268-8800 Fax: 614-268-8249 | |
Lindsay R Eckman, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3555 Olentangy River Rd Ste 4050, Columbus, OH 43214 Phone: 614-566-2727 Fax: 614-566-2712 | |
Mary Ann Chambers, BSN Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 240 Parsons Ave, Columbus, OH 43215 Phone: 614-645-1850 |